BRECKENRIDGE PHARMACEUTICAL — Everolimus Importer Profile
Pharmaceutical Importer · #11 buyer for Everolimus · $4.3M import value · 113 shipments · UNITED STATES · DGFT Verified
BRECKENRIDGE PHARMACEUTICAL is the #11 importer of Everolimus from India with $4.3M in import value and 113 verified shipments. BRECKENRIDGE PHARMACEUTICAL holds a 3.5% market share in Everolimus imports based in UNITED STATES. The company sources from 1 verified supplier across 99 formulations shipped to 1 country.
BRECKENRIDGE PHARMACEUTICAL — Everolimus Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Everolimus to BRECKENRIDGE PHARMACEUTICAL?
Verified from 113 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NATCO PHARMA LIMITED | $4.3M | 113 | 100.0% |
BRECKENRIDGE PHARMACEUTICAL sources Everolimus from 1 verified Indian supplier based on 113 customs records. The primary supplier is NATCO PHARMA LIMITED accounting for 100.0% of imports.
How Does BRECKENRIDGE PHARMACEUTICAL Compare to Nearest Everolimus Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | ASCEND LABORATORIES,LLC | UNITED STATES | $1.4M | 27 | $50.0K |
| 8 | BRECKENRIDGE PHARMACEUTICAL, INC | UNITED STATES | $1.1M | 21 | $50.0K |
| 11 | BRECKENRIDGE PHARMACEUTICAL ★ | UNITED STATES | $1.1M | 21 | $50.0K |
| 9 | NATCOFARMA DO BRASIL LTDA, | BRAZIL | $550.0K | 11 | $50.0K |
| 7 | BRECKENRIDGE PHARMACEUTICALS INC | UNITED STATES | $350.0K | 7 | $50.0K |
BRECKENRIDGE PHARMACEUTICAL ranks #11 among 135 Everolimus importers from India. Average shipment value of $50.0K compared to the market average of $105.8K. The closest competitors by value are ASCEND LABORATORIES,LLC and BRECKENRIDGE PHARMACEUTICAL, INC.
Where Does BRECKENRIDGE PHARMACEUTICAL Import Everolimus To?
Destination countries from 113 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.3M | 113 | 100.0% |
BRECKENRIDGE PHARMACEUTICAL imports Everolimus to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $4.3M.
What Everolimus Formulations Does BRECKENRIDGE PHARMACEUTICAL Import?
| Formulation | Value | Shipments |
|---|---|---|
| EVEROLIMUS 0.5MG TABLETS 60S (4952X 60S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:123270)NOS | $165.3K | 6 |
| EVEROLIMUS 10MG TABLETS 28'S (OTHER REFE | $150.0K | 3 |
| EVEROLIMUS 10MG TABLETS 28S (1171 X 28S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S) CI NO:123243)NOS | $138.7K | 3 |
| EVEROLIMUS 10MG TABLETS 28 S APPENDIX 4R RODTEP ENTRY NO 10112 OTHER REFERENCE S CI NO 122283 | $100.0K | 2 |
| EVEROLIMUS 7.5MG TABLETS 28'S (OTHER REF | $50.0K | 1 |
| EVEROLIMUS 2.5MG TABLETS 28'S (OTHER REF | $50.0K | 1 |
| EVEROLIMUS 0.25MG TABLETS 60'S (OTHER RE | $50.0K | 1 |
| EVEROLIMUS 0.75MG TABLETS 60'S (OTHER RE | $50.0K | 1 |
| EVEROLIMUS 0.5MG TABLETS 60'S (OTHER REF | $50.0K | 1 |
| EVEROLIMUS 0.75MG TABLETS 60'S (7102 X 6 | $50.0K | 1 |
BRECKENRIDGE PHARMACEUTICAL imports 99 distinct Everolimus formulations from India. The top formulation is EVEROLIMUS 0.5MG TABLETS 60S (4952X 60S) (APPENDIX 4R, RODTE with 6 shipments worth $165.3K.
Regulatory Requirements: Importing Everolimus into United States
What BRECKENRIDGE PHARMACEUTICAL and other importers must comply with to import Everolimus from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Everolimus
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Everolimus from India and How Much Does BRECKENRIDGE PHARMACEUTICAL Import?
India exported $14.3M worth of Everolimus through 620 shipments from 87 suppliers to 67 countries, serving 135 buyers globally. BRECKENRIDGE PHARMACEUTICAL imports $4.3M of this total, accounting for 3.5% of India's Everolimus exports with 113 shipments from UNITED STATES. This is verified from 113 customs shipment records covering 99 distinct formulations.
What Is the Average Order Value for BRECKENRIDGE PHARMACEUTICAL's Everolimus Imports?
BRECKENRIDGE PHARMACEUTICAL's average Everolimus order value is $37.7K per consignment, based on 113 shipments totaling $4.3M. BRECKENRIDGE PHARMACEUTICAL is based in UNITED STATES and ranks #11 among all Everolimus importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Everolimus to BRECKENRIDGE PHARMACEUTICAL?
BRECKENRIDGE PHARMACEUTICAL sources Everolimus from 1 verified Indian supplier: NATCO PHARMA LIMITED ($4.3M, 100.0%). This is based on 113 customs records.
How Does BRECKENRIDGE PHARMACEUTICAL Compare to Other Everolimus Importers?
BRECKENRIDGE PHARMACEUTICAL ranks #11 among 135 Everolimus importers from India with a 3.5% market share. The top 3 importers are BRECKENRIDGE PHARMACEUTICAL INC ($3.1M), PHARMACARE PREMIUM ($2.3M), ASCEND LABORATORIES LLC ($1.9M). BRECKENRIDGE PHARMACEUTICAL processed 113 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Everolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Everolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BRECKENRIDGE PHARMACEUTICAL matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BRECKENRIDGE PHARMACEUTICAL's capped import value divided by total capped export value for Everolimus across all Indian exporters.
- 5.Verified Records: This page is backed by 113 individual customs records matching BRECKENRIDGE PHARMACEUTICAL importing Everolimus, covering 99 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Everolimus Import Data for BRECKENRIDGE PHARMACEUTICAL
Access order-level details, pricing data, supplier connections, and competitive analysis for BRECKENRIDGE PHARMACEUTICAL's Everolimus imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BRECKENRIDGE PHARMACEUTICAL
Company Profile
Multiple products · $0 total trade · Multiple categories
BRECKENRIDGE PHARMACEUTICAL × Everolimus
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BRECKENRIDGE PHARMACEUTICAL.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Everolimus. For current order-level data, contact TransData Nexus.